People: Global Bioenergies SA (ALGBE.PA)

ALGBE.PA on Paris Stock Exchange

36.00EUR
20 Aug 2014
Price Change (% chg)

€0.01 (+0.03%)
Prev Close
€35.99
Open
€36.00
Day's High
€36.14
Day's Low
€35.95
Volume
547
Avg. Vol
980
52-wk High
€49.00
52-wk Low
€24.15

Search Stocks

Summary

Name Age Since Current Position

Marc Delcourt

41 2009 Chairman of the Board and Chief Executive Officer

Liliane Bronstein

2010 Administrative and Financial Director, Investor Relations Officer

Frederic Paques

2013 Chief Technology Officer

Richard Bockrath

2012 Vice President for Chemical Engineering

Charles Nakamura

2012 Vice President for Metabolic Engineering

Thomas Buhl

2010 Director of Business Development

Sebastien Groyer

32 2012 Director - Permanent Representative of Seventure Partners

Philippe Marliere

2009 Director

Biographies

Name Description

Marc Delcourt

Dr. Marc Delcourt, Ph.D. has been Chairman of the Board and Chief Executive Officer of Global Bioenergies SA since February 13, 2009. After his scientific training (he obtained a degree in Biology from Ecole Normale Superieure and a Ph.D in Molecular Biology in Canada), Dr. Delcourt turned towards research and development activities in the field of bioprocesses and founded in 1997 the industrial biotech company Biomethodes where he served as Chairman of the Board and Chief Executive Officer. He left Biomethodes in 2008 to found Global Bioenergies SA.

Liliane Bronstein

Ms. Liliane Bronstein has been Administrative and Financial Director, Investor Relations Officer of Global Bioenergies SA since 2010. From 1997, she was the financial director of listed European companies in the high tech and information technology (IT). She led several operations in corporate finance (IPO, M&A). Ms. Bronstein holds a Masters Degree in Finance.

Frederic Paques

Mr. Frederic Paques has been Chief Technology Officer at Global Bioenergies SA since June 10, 2013. He holds a PhD. in molecular genetics and, following an academic career in France and the USA, he left the CNRS in 2001 to join the company Cellectis where he has acted as Scientific Director for over 10 years.

Richard Bockrath

Dr. Richard E. Bockrath has served as Vice President for Chemical Engineering at Global Bioenergies SA since May 9, 2012. He is a former Technical Director at DuPont, has contributed to the industrialization of numerous processes, including ones in the field of industrial biology. He received a Doctorate in Philosophy in Chemical Engineering from Massachusetts Institute of Technology in 1981.

Charles Nakamura

Dr. Charles E. Nakamura has served as Vice President for Metabolic Engineering at Global Bioenergies SA as of May 9, 2012. He is a former Senior Research Fellow at DuPont, has led the generation of industrial production strains and the development of fermentation processes. He received a Doctorate in Philosophy in Biochemistry from Brandeis University in 1986.

Thomas Buhl

Mr. Thomas Buhl has been Director of Business Development of Global Bioenergies SA since October 2010. He holds a Master of Science in Biotechnology and a biotech-focused Master's in business administration. Mr. Buhl started his career in the technology transfer office of the C.E.A. He then became Business Development Manager at Biomethodes and subsequently took over the responsibility for the strategic development of MorphoSys, a German biotech company.

Sebastien Groyer

Mr. Sebastien Groyer has been Director - Permanent Representative of Seventure Partners of Global Bioenergies SA since October 23, 2012. He previously served as Director - Permanent Representative of Masseran Gestion of the Company from February 13, 2009. He has been the Investment Director of Masseran Gestion, a subsidiary of GCE Capital, owned by BPCE Group. He holds and degree in Biotechnology Engineering from Universite de Technologie de Compiegne and a Masters degree in Political and Economic Philosophy from Universite Paris 1 Pantheon Sorbonne. He currently serves as a Director of Proviciel, Balyo, Domain Therapeutics and Lucane Pharma, and a Member of the Supervisory Board of Nanobiotix.

Philippe Marliere

Dr. Philippe Marliere has been Director of Global Bioenergies SA since February 13, 2009. He is the co-founder of the Company. A graduate of Ecole Normale Superieure, he has focused on the launch of the field of synthetic biology during his academic career. He has since pursued his scientific work in several biotechnology companies that he has founded or cofounded. As a scientific partner of the CEA (a French research organization for applied sciences) he advises the Director of Life Sciences in the fields of bioenergy and synthetic biology. Dr. Marliere currently serves as Chairman of Heurisko Inc and Director of Scientist of Fortune. During the last five years, he has also served as President of Societe Marliere Technologies.

Basic Compensation

Search Stocks